Peri-implantitis Market Size, Share & Industry Analysis, By Method Type (Surgical [Bone Regeneration, Open Flap Debridement, Implantoplasty], Non- Surgical [Mechanical Debridement, Laser Debridement, Antibiotics]Others), By End User (Hospitals, Dental Clinics, Others) And Regional Forecast, 2024-2032

Peri-implantitis is an infectious ailment or dental condition that affects the soft and hard tissue surrounding a dental implant. An inflammatory response is seen in patients with loss of supporting bone in the tissues around the dental implant. The initial success rate of dental implants is considered to be around 80-90% across the globe. However, 10%–20% of the tooth prosthetics/implants displayed signs of peri-implantitis after 15 years of the procedure. The primary symptom of peri-implantitis comprises severe toothache, feeling of the implant becoming loose, swelling of the gum, and discomfort. 

The peri-implantitis market is expected to register an astonishing growth during the forecast period due to factors such rising number of implants being adopted in the developed economies such as U.S., escalating health-consciousness, and growing number of product launches by the key players. However, high cost of dental procedures and lack of awareness are factors that restrain the peri-implantitis market in developing countries.

Key Market Driver -

Rising prevalence of chronic dental ailments

Key Market Restraint -

High treatment cost

Market Segmentation:

Globally, the peri-implantitis market can be segmented on the basis of the method type, end user, and region. Based on the method type, the market can be segmented into surgical and non-surgical. The surgical segment can be further classified into bone regeneration, open flap debridement, and implantoplasty, while the non-surgical segment is sub segmented into mechanical debridement, laser debridement, antibiotics and others. Based on end user, the market can be segmented into hospitals, dental clinics and others. Geographically, the peri-implantitis market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

Key Players Covered:

Some of the major companies that are present in the peri-implantitis market are Pfizer Inc., Cadila Pharmaceuticals, R.N. Laboratories Pvt. Ltd., Basic Pharma Life Science Pvt. Ltd, Prachi Pharmaceuticals Private Limited, Geistlich Pharma Inc., Healthy Life Pharma and other prominent players.  

Key Insights:

• Key Industry Trends


• Regulatory and Reimbursement Scenario


• New Product Launches


• Key Industry Developments Mergers, Acquisitions, And Collaborations

Regional Analysis:

Geographically, the peri-implantitis market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is anticipated to account for majority of the share of the peri-implantitis market owing to the growing burden of dental diseases, and well-developed healthcare facilities. Europe is expected to hold the second largest market share during the forecast period. Increasing initiatives by the market players for technological advancements in peri-implantitis devices and highly aware population is likely to fuel the market growth in this region. On the other hand, Asia Pacific is expected to grow with the highest growth rate during the forecast period owing to rising number of market players focusing on the launch of dental equipment. The market in Latin America and the Middle East & Africa are expected to showcase substantial growth during the forecast period.

To gain extensive insights into the market, Request for Customization

Segmentation

Peri-implantitis Market Industry Developments

• In November 2020, Aspen Dental Management (ADMI) announced it has reached an agreement with Sun Capital Partners, Inc. to acquire ClearChoice Management Services (CCMS), which provides comprehensive practice support services to the nationwide network of ClearChoice Dental Implant Centers.


• In January 2019, OraCare announced the launch of implant post-op care system. The new system is designed to prevent development of peri-implantitis by targeting the specific microorganisms and compounds known to cause the complication.